5 min listen
Treatment Effects & Transition to Survivorship for AYA Patients
FromASCO Education
ratings:
Length:
8 minutes
Released:
Apr 18, 2018
Format:
Podcast episode
Description
Cindy Schwartz, MD, MPH, is an accomplished oncologist who brings 35 years of experience, passion and expertise in the areas of Hodgkin lymphoma, osteosarcoma and childhood cancer survivorship.
Released:
Apr 18, 2018
Format:
Podcast episode
Titles in the series (100)
Recently Approved Drugs: Pembrolizumab for cHL: Recently Approved Drugs: Pembrolizumab for cHL by ASCO Education